New

Spine Biologics Market

2021

Spine Biologics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Bone Graft Substitutes, Spinal Allografts, Cell-based Matrix); End User (Hospitals, ASCs) and Geography

| Report Code: TIPRE00006818 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Market Insights

Spine Biologics Market 2028 By Product, End User and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Spine biologics are utilized at the time of spine fusion surgery for the treatment of spinal deformities and disorders such as, tumors, trauma, spinal cord injuries and degenerative disc disease by stimulating bone growth formation through repair stage, inflammatory stage and remodeling stage. Therefore, increase in the number of spinal fusion surgeries have fueled the utilization of biologics. The key factors driving the market growth of spine biologics are, rising geriatric population across the globe and various benefits provided by the biologics.

MARKET SCOPE

The "Global Spine Biologics Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the spine biologics market with detailed market segmentation by product and end user. The report provides key statistics on the market status of the leading spine biologics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •   Based on product the market is segmenetd as, bone graft substitutes, spinal allografts, cell-based matrix.
  •   Based on end user the market is bifurcated as, hospitals and ASCs.

MARKET DYNAMICS
Drivers:

  •   Increasing geriatric population along with rising prevalence of spine and related disorders.
  •   Benefits of biologics such as, faster recovery, minimal postoperative time and ability to activate cellular growth.
  •   Advancements in bone grafting procedures along with rising demand for minimally invasive procedures.

Restraints:

  •   However, the market's growth is restrained by an unfavourable reimbursement scenario, higher bone graft costs, and ethical concerns about bone grafting procedures.



Get more information on this report :

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The spine biologics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the spine biologics market in these regions.

IMPACT OF COVID-19 ON SPINE BIOLOGICS MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the spine biologics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from spine biologics market are anticipated to lucrative growth opportunities in the future with the rising demand for spine biologics in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the spine biologics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Stryker
  •   Orthofix Medical Inc
  •   NuVasive, Inc.
  •   NuTech Spine, Inc.
  •   Medical Devices Business Services, Inc
  •   Wright Medical Group N.V.
  •   Exactech, Inc
  •   Zimmer Biomet
  •   Arthrex, Inc.
  •   Medtronic
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Spine Biologics Market - By Product
1.3.2 Spine Biologics Market - By End User
1.3.3 Spine Biologics Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. SPINE BIOLOGICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. SPINE BIOLOGICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. SPINE BIOLOGICS MARKET - GLOBAL MARKET ANALYSIS
6.1. SPINE BIOLOGICS - GLOBAL MARKET OVERVIEW
6.2. SPINE BIOLOGICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. SPINE BIOLOGICS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. BONE GRAFT SUBSTITUTES
7.3.1. Overview
7.3.2. Bone Graft Substitutes Market Forecast and Analysis
7.4. SPINAL ALLOGRAFTS
7.4.1. Overview
7.4.2. Spinal Allografts Market Forecast and Analysis
7.5. CELL-BASED MATRIX
7.5.1. Overview
7.5.2. Cell-based Matrix Market Forecast and Analysis
8. SPINE BIOLOGICS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. ASCS
8.4.1. Overview
8.4.2. ASCs Market Forecast and Analysis

9. SPINE BIOLOGICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Spine Biologics Market Overview
9.1.2 North America Spine Biologics Market Forecasts and Analysis
9.1.3 North America Spine Biologics Market Forecasts and Analysis - By Product
9.1.4 North America Spine Biologics Market Forecasts and Analysis - By End User
9.1.5 North America Spine Biologics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Spine Biologics Market
9.1.5.1.1 United States Spine Biologics Market by Product
9.1.5.1.2 United States Spine Biologics Market by End User
9.1.5.2 Canada Spine Biologics Market
9.1.5.2.1 Canada Spine Biologics Market by Product
9.1.5.2.2 Canada Spine Biologics Market by End User
9.1.5.3 Mexico Spine Biologics Market
9.1.5.3.1 Mexico Spine Biologics Market by Product
9.1.5.3.2 Mexico Spine Biologics Market by End User
9.2. EUROPE
9.2.1 Europe Spine Biologics Market Overview
9.2.2 Europe Spine Biologics Market Forecasts and Analysis
9.2.3 Europe Spine Biologics Market Forecasts and Analysis - By Product
9.2.4 Europe Spine Biologics Market Forecasts and Analysis - By End User
9.2.5 Europe Spine Biologics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Spine Biologics Market
9.2.5.1.1 Germany Spine Biologics Market by Product
9.2.5.1.2 Germany Spine Biologics Market by End User
9.2.5.2 France Spine Biologics Market
9.2.5.2.1 France Spine Biologics Market by Product
9.2.5.2.2 France Spine Biologics Market by End User
9.2.5.3 Italy Spine Biologics Market
9.2.5.3.1 Italy Spine Biologics Market by Product
9.2.5.3.2 Italy Spine Biologics Market by End User
9.2.5.4 Spain Spine Biologics Market
9.2.5.4.1 Spain Spine Biologics Market by Product
9.2.5.4.2 Spain Spine Biologics Market by End User
9.2.5.5 United Kingdom Spine Biologics Market
9.2.5.5.1 United Kingdom Spine Biologics Market by Product
9.2.5.5.2 United Kingdom Spine Biologics Market by End User
9.2.5.6 Rest of Europe Spine Biologics Market
9.2.5.6.1 Rest of Europe Spine Biologics Market by Product
9.2.5.6.2 Rest of Europe Spine Biologics Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Spine Biologics Market Overview
9.3.2 Asia-Pacific Spine Biologics Market Forecasts and Analysis
9.3.3 Asia-Pacific Spine Biologics Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Spine Biologics Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Spine Biologics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Spine Biologics Market
9.3.5.1.1 Australia Spine Biologics Market by Product
9.3.5.1.2 Australia Spine Biologics Market by End User
9.3.5.2 China Spine Biologics Market
9.3.5.2.1 China Spine Biologics Market by Product
9.3.5.2.2 China Spine Biologics Market by End User
9.3.5.3 India Spine Biologics Market
9.3.5.3.1 India Spine Biologics Market by Product
9.3.5.3.2 India Spine Biologics Market by End User
9.3.5.4 Japan Spine Biologics Market
9.3.5.4.1 Japan Spine Biologics Market by Product
9.3.5.4.2 Japan Spine Biologics Market by End User
9.3.5.5 South Korea Spine Biologics Market
9.3.5.5.1 South Korea Spine Biologics Market by Product
9.3.5.5.2 South Korea Spine Biologics Market by End User
9.3.5.6 Rest of Asia-Pacific Spine Biologics Market
9.3.5.6.1 Rest of Asia-Pacific Spine Biologics Market by Product
9.3.5.6.2 Rest of Asia-Pacific Spine Biologics Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Spine Biologics Market Overview
9.4.2 Middle East and Africa Spine Biologics Market Forecasts and Analysis
9.4.3 Middle East and Africa Spine Biologics Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Spine Biologics Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Spine Biologics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Spine Biologics Market
9.4.5.1.1 South Africa Spine Biologics Market by Product
9.4.5.1.2 South Africa Spine Biologics Market by End User
9.4.5.2 Saudi Arabia Spine Biologics Market
9.4.5.2.1 Saudi Arabia Spine Biologics Market by Product
9.4.5.2.2 Saudi Arabia Spine Biologics Market by End User
9.4.5.3 U.A.E Spine Biologics Market
9.4.5.3.1 U.A.E Spine Biologics Market by Product
9.4.5.3.2 U.A.E Spine Biologics Market by End User
9.4.5.4 Rest of Middle East and Africa Spine Biologics Market
9.4.5.4.1 Rest of Middle East and Africa Spine Biologics Market by Product
9.4.5.4.2 Rest of Middle East and Africa Spine Biologics Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Spine Biologics Market Overview
9.5.2 South and Central America Spine Biologics Market Forecasts and Analysis
9.5.3 South and Central America Spine Biologics Market Forecasts and Analysis - By Product
9.5.4 South and Central America Spine Biologics Market Forecasts and Analysis - By End User
9.5.5 South and Central America Spine Biologics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Spine Biologics Market
9.5.5.1.1 Brazil Spine Biologics Market by Product
9.5.5.1.2 Brazil Spine Biologics Market by End User
9.5.5.2 Argentina Spine Biologics Market
9.5.5.2.1 Argentina Spine Biologics Market by Product
9.5.5.2.2 Argentina Spine Biologics Market by End User
9.5.5.3 Rest of South and Central America Spine Biologics Market
9.5.5.3.1 Rest of South and Central America Spine Biologics Market by Product
9.5.5.3.2 Rest of South and Central America Spine Biologics Market by End User

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. SPINE BIOLOGICS MARKET, KEY COMPANY PROFILES
11.1. STRYKER
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ORTHOFIX MEDICAL INC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. NUVASIVE, INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. NUTECH SPINE, INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. MEDICAL DEVICES BUSINESS SERVICES, INC
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. WRIGHT MEDICAL GROUP N.V.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. EXACTECH, INC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. ZIMMER BIOMET
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. ARTHREX, INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. MEDTRONIC
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Stryker
2. Orthofix Medical Inc
3. NuVasive, Inc.
4. NuTech Spine, Inc.
5. Medical Devices Business Services, Inc
6. Wright Medical Group N.V.
7. Exactech, Inc
8. Zimmer Biomet
9. Arthrex, Inc.
10. Medtronic
TIPRE00006818
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.